Identification | Back Directory | [Name]
GSK-CXCR2 | [CAS]
211096-49-0 | [Synonyms]
GSK-CXCR2 SB 265610 SB265610 >=98% (HPLC) N-(2-Bromophenyl)-N'-(7-cyano-1H-benzotriazol-4-yl)urea Urea, N-(2-bromophenyl)-N'-(4-cyano-1H-benzotriazol-7-yl)- 1-(2-Bromophenyl)-3-(4-cyano-1H-benzo[d] [1,2,3]triazol-7-yl)urea | [Molecular Formula]
C14H9BrN6O | [MDL Number]
MFCD09971124 | [MOL File]
211096-49-0.mol | [Molecular Weight]
357.16 |
Chemical Properties | Back Directory | [Boiling point ]
527.0±45.0 °C(Predicted) | [density ]
1.77±0.1 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: soluble15mg/mL, clear | [form ]
powder | [pka]
6.13±0.40(Predicted) | [color ]
white to light brown |
Hazard Information | Back Directory | [Uses]
SB 265610 is an anti-tumor pharmaceutical developed to act as an antagonist to cysteine-amino acid-cysteine (CXC) chemokines receptor 2 antagonist. | [Biological Activity]
Potent CXCR2 antagonist that inhibits CINC-1-mediated but not C5a-mediated Ca 2+ mobilization (IC 50 values are 3.4 and 6800 nM respectively). Inhibits CINC-induced chemotaxis and attenuates neutrophil accumulation in inflammatory lung injury in vivo . | [Biochem/physiol Actions]
SB265610 is a potent and selective CXCR2 chemokine receptor antagonist. It has a Kd = 2.5 nM. | [storage]
Store at RT |
|
Company Name: |
Sigma-Aldrich
|
Tel: |
021-61415566 800-8193336 |
Website: |
https://www.sigmaaldrich.cn |
|